Grant supports gene-editing research for rare metabolic diseases

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP).

Ten biotech executives who reaped the biggest M&A windfalls, netting $40M+ exit packages

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 12, 2024

European Commission reaches deal with Vifor for ‘disparaging’ its only rival in iron deficiency market

Following a two-year probe, the European Commission has formalized a proposal from Vifor Pharma to resolve allegations that the company spread misleading information about a

July 22, 2024

Hospitals See Strong Financial Performance in April, Despite Rising Expenses

What You Should Know: – U.S. hospitals and health systems continued to experience positive financial performance in April, with patient demand and revenues rising for

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.